We have previously found that skeletal muscle becomes electrically inexcitable in septic patients. Work in an animal model suggests that a decrease in the available sodium current underlies the loss of electrical excitability. We examined ECGs from patients during periods of septic shock to determine whether there were any ECG abnormalities that might suggest a similar loss of excitability in cardiac tissue during sepsis. Fourteen out of 17 patients had low or significantly decreased QRS amplitudes during septic shock; 8 of 17 had long or increased QRS duration with or without bundle branch block. The mean decrease in QRS amplitude in septic patients was 41%, significantly higher than in controls where no consistent decrease in QRS amplitude was found (p < 0.01). In patients who recovered from septic shock, the QRS amplitude and the increased QRS duration both returned to normal. We conclude that there is a loss of QRS amplitude during septic shock that may be due to altered cardiac excitability.

Keywords:
Cardiac excitability, Sepsis, Systemic inflammatory response syndrome, Low QRS voltage
1.
Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731–736.
2.
Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW: Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665–673.
3.
Rich MM, Pinter MJ, Kraner SD, Barchi RL: Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurology 1998;43:171–179.
4.
Rich MM, Pinter MJ: Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001;50:26–33.
5.
Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976–1981.
6.
Hallstrom S, Koidl B, Muller U, Werdan K, Schlag G: A cardiodepressant factor isolated from blood blocks Ca2+ current in cardiomyocytes. Am J Physiol 1991;260:H869–H876.
7.
Thomas F, Smith JL, Orme JF, Clemmer TP, Hagan AD, Elliott CG, Vincent GM: Reversible segmental myocardial dysfunction in septic shock. Crit Care Med 1986;14:587–588.
8.
Grocott-Mason RM, Shah AM: Cardiac dysfunction in sepsis: New theories and clinical implications. Intensive Care Med 1998;24:286–295.
9.
Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW: Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995;27:155–167.
10.
Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483–490.
11.
Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE: Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988;93:903–910.
12.
Toney JF, Parker MM: New perspectives on the management of septic shock in the cancer patient. Infect Dis Clin North Am 1996;10:239–253.
13.
Müller-Hocker J, Haerty W: Pathomorphological aspects of heart in septic patients; in Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis and Organ Failure. Berlin, Springer, 1993, pp 853–858.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.